Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 513

1.
2.

Liver resection in advanced hepatocellular carcinoma.

Usatoff V, Isla AM, Habib NA.

Hepatogastroenterology. 2001 Jan-Feb;48(37):46-50.

PMID:
11268996
3.

Chromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization.

Kakar S, Chen X, Ho C, Burgart LJ, Sahai V, Dachrut S, Yabes A, Jain D, Ferrell LD.

Mod Pathol. 2009 Jan;22(1):134-41. doi: 10.1038/modpathol.2008.178. Epub 2008 Nov 7.

4.

Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver.

Chang CH, Chau GY, Lui WY, Tsay SH, King KL, Wu CW.

Arch Surg. 2004 Mar;139(3):320-5; discussion 326.

PMID:
15006892
5.

Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history.

Epstein BE, Pajak TF, Haulk TL, Herpst JM, Order SE, Abrams RA.

Am J Clin Oncol. 1999 Feb;22(1):22-8.

PMID:
10025374
6.

HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.

Schoedel KE, Tyner VZ, Kim TH, Michalopoulos GK, Mars WM.

Mod Pathol. 2003 Jan;16(1):14-21.

7.
8.

Pedunculated hepatocellular carcinoma: clinicopathologic study of 18 surgically resected cases.

Yeh CN, Lee WC, Jeng LB, Chen MF.

World J Surg. 2002 Sep;26(9):1133-8. Epub 2002 Jun 24.

PMID:
12209243
9.

Outcome of patients with fibrolamellar hepatocellular carcinoma.

Stipa F, Yoon SS, Liau KH, Fong Y, Jarnagin WR, D'Angelica M, Abou-Alfa G, Blumgart LH, DeMatteo RP.

Cancer. 2006 Mar 15;106(6):1331-8.

10.
11.

Treatment and prognosis of hepatocellular carcinoma: a population based study in France.

Borie F, Bouvier AM, Herrero A, Faivre J, Launoy G, Delafosse P, Velten M, Buemi A, Peng J, Grosclaude P, Tr├ętarre B.

J Surg Oncol. 2008 Dec 1;98(7):505-9. doi: 10.1002/jso.21159.

PMID:
18932235
12.

Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors.

Ward SC, Waxman S.

Semin Liver Dis. 2011 Feb;31(1):61-70. doi: 10.1055/s-0031-1272835. Epub 2011 Feb 22. Review.

PMID:
21344351
13.

Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.

Dohmen K, Shirahama M, Shigematsu H, Irie K, Ishibashi H.

Hepatogastroenterology. 2004 Mar-Apr;51(56):564-9.

PMID:
15086203
14.

Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers.

Lang H, Sotiropoulos GC, Brokalaki EI, Schmitz KJ, Bertona C, Meyer G, Frilling A, Paul A, Malag├│ M, Broelsch CE.

J Am Coll Surg. 2007 Jul;205(1):27-36.

PMID:
17617329
15.

Fibrolamellar hepatocellular carcinoma: stage at presentation and results of aggressive surgical management.

Stevens WR, Johnson CD, Stephens DH, Nagorney DM.

AJR Am J Roentgenol. 1995 May;164(5):1153-8.

PMID:
7717223
16.

Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival--a European single center experience.

Capussotti L, Muratore A, Amisano M, Polastri R, Bouzari H, Massucco P.

Eur J Surg Oncol. 2005 Nov;31(9):986-93. Epub 2005 Jun 3.

PMID:
15936169
17.

Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma.

Yoneyama K, Taniguchi H, Kiuchi Y, Shibata M, Mitamura K.

Scand J Gastroenterol. 2004 Dec;39(12):1272-9.

PMID:
15743006
18.
19.

[Prognostic factors influencing postoperative survival in patients with </= 3 cm small hepatocellular carcinoma].

Wu FS, Zhao WH, Liang TB, Ren GP, Ma ZM, Teng LS.

Zhonghua Wai Ke Za Zhi. 2005 May 1;43(9):579-83. Chinese.

PMID:
15938929
20.

Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.

Teh SH, Sheppard BC, Schwartz J, Orloff SL.

Am J Surg. 2008 May;195(5):697-701. doi: 10.1016/j.amjsurg.2007.05.054.

PMID:
18367132

Supplemental Content

Support Center